Your browser doesn't support javascript.
loading
Research progress of biomineralization for the diagnosis and treatment of malignant tumors.
Wu, Yulu; Pan, Xun; Xie, Huixu; Que, Lin; Tang, Xiufa.
Afiliación
  • Wu Y; West China School of Stomatology, Sichuan University, Chengdu, China.
  • Pan X; State Key Laboratory of Oral Diseases, West China School of Stomatology, Sichuan University, Chengdu, China.
  • Xie H; West China School of Stomatology, Sichuan University, Chengdu, China.
  • Que L; State Key Laboratory of Oral Diseases, West China School of Stomatology, Sichuan University, Chengdu, China.
  • Tang X; West China School of Stomatology, Sichuan University, Chengdu, China.
Front Pharmacol ; 14: 1335019, 2023.
Article en En | MEDLINE | ID: mdl-38155903
ABSTRACT
Malignant tumors have long been a prominent subject of research in order to foster innovation and advancement in diagnostic and therapeutic modalities. However, the current clinical treatment of malignant tumors faces significant limitations. In light of recent advancements, the World Health Organization (WHO) officially designated malignant tumors as a chronic disease in 2006. Accordingly, maintaining the tumor in a stable state and minimizing its detrimental impact on the body emerges as a potentially advantageous approach to oncological treatment. One emerging strategy that has garnered substantial attention from the academic community is the construction of a biomineralized layer surrounding solid tumors for tumor blockade therapy. This innovative approach is regarded as safe, effective, and long-lasting. This review aims to provide a comprehensive summary of the advancements made in the utilization of biomineralization for the diagnosis and treatment of malignant tumors.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Front Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza